Remimazolam Versus Dexmedetomidine for Monitored Anesthesia Care in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Randomized Clinical Trial
Journal of Clinical Medicine · 16.09.2026 · 15 (18) · 7182
DOI: 10.3390/jcm15187182 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.09.2026. Verfasst von Sung-Woo Hyung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Re…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hana Pharm (South Korea), Hana Pharm Co., Ltd., Eunpyeong St. Mary's Hospital.
Abstract (Originalsprache)
Background/Objectives: Monitored anesthesia care is increasingly used for transfemoral transcatheter aortic valve implantation (tf-TAVI), but the optimal sedative regimen remains uncertain. We compared remimazolam with dexmedetomidine during tf-TAVI. Methods: In this single-center randomized trial, 34 patients were assigned 1:1 to remimazolam or dexmedetomidine. Primary outcomes were the number of intraoperative hypotensive episodes, defined as mean arterial pressure
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.
- Department of Anesthesiology and Pain Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon 14647, Republic of Korea.
- Department of Anesthesiology and Pain Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Sung-Woo Hyung, Wonjung Hwang
Förderung
- Hana Pharm (South Korea)
- Hana Pharm Co., Ltd.
- Eunpyeong St. Mary's Hospital
Zitieren
APA
Hyung, S. W., Choi, M., Chung, M. Y., & Hwang, W. (2026). Remimazolam Versus Dexmedetomidine for Monitored Anesthesia Care in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Randomized Clinical Trial. Journal of Clinical Medicine, 15(18), 7182. https://doi.org/10.3390/jcm15187182
Vancouver
Hyung SW, Choi M, Chung MY, Hwang W. Remimazolam Versus Dexmedetomidine for Monitored Anesthesia Care in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Randomized Clinical Trial. Journal of Clinical Medicine. 2026;15(18):7182. doi:10.3390/jcm15187182
BibTeX
@article{Hyung2026,
author = {Hyung, Sung-Woo and Choi, Myokyung and Chung, Mee Young and Hwang, Wonjung},
title = {Remimazolam Versus Dexmedetomidine for Monitored Anesthesia Care in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Randomized Clinical Trial},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {18},
pages = {7182},
doi = {10.3390/jcm15187182}
}
EUVIMED